Navigation Links
ASTRO publishes evidence-based guideline for thoracic radiotherapy
Date:4/27/2011

The American Society for Radiation Oncology (ASTRO) has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO.

Many patients whose lung cancer has spread receive radiation therapy to treat symptoms related to cancer, such as cough, shortness of breath, bronchial obstruction and chest pain. However, the exact treatment approach can vary from doctor to doctor. This variation caused the Guidelines Subcommittee of ASTRO's Clinical Affairs and Quality Committee (CAQC) to identify the use of palliative thoracic (or chest) radiation therapy as a high-priority topic needing an evidence-based guideline.

This panel was co-chaired by George Rodrigues, MD, MSc, a radiation oncologist and clinician scientist at London Health Sciences Centre in London, Ontario, Canada, and Benjamin Movsas, MD, chairman of radiation oncology at Henry Ford Health System in Detroit.

"Radiation therapy can be extremely helpful to alleviate symptoms caused by lung cancer, such as shortness of breath and chest pain," Dr. Rodrigues said.

ASTRO's Board of Directors then put together a multidisciplinary task force that was charged with reviewing and synthesizing the current evidence to develop a guideline to help radiation oncologists determine the appropriate use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy for palliative intent for lung cancer patients.

The task force's main findings are:

1. Various regimens of thoracic external beam radiation therapy are very effective for palliation of symptoms, with moderately higher dose regimens associated with a modest improvement in survival for selected patients primarily with good performance status.

2. There is no evidence to recommend the use of endobronchial brachytherapy in the routine initial palliative management of lung cancer. Endobronchial brachytherapy is a type of internal radiation therapy used to treat lung cancer in or near the patient's airway.

3. There is no added benefit to patients to use chemotherapy at the same time as radiation therapy in the relief of thoracic symptoms for lung cancer patients. However, optimally integrating sequential chemotherapy and radiation therapy is important in the management of lung cancer symptoms.

Dr. Movsas said, "It is our hope that this evidence-based guideline will help doctors determine the optimal palliative radiation treatments for lung cancer patients, thereby yielding improved quality of life."


'/>"/>

Contact: Beth Bukata
bethb@astro.org
703-839-7332
American Society for Radiation Oncology
Source:Eurekalert

Related medicine news :

1. Senate Committee Advances Disastrous Idaho Health Freedom Act
2. ReportsandReports : The Gastrointestinal Market Outlook to 2014: Market Dynamics, Competitive Landscape, Emerging Therapies
3. ASTRO awards 17 Advocacy Day travel grants
4. ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects
5. Santa Monica Jury Rejects Claims of Catastrophic Brain Injury From Exposure to Mold; Plaintiff Faces Motions for Attorney Fees and Costs
6. Astrogenetix Narrows in on MRSA Virulence Onboard Discovery
7. A new endoscopic technique for gastrointestinal perforations: the over-the-scope-clip
8. ASTRO president speaks on prostate cancer at MEDCAC meeting
9. ASTRO applauds nomination of Dr. Donald Berwick to head Centers for Medicare and Medicaid Services
10. Outstanding young gastroenterologists receive AGA Foundation
11. Outstanding young gastroenterologists receive AGA Foundation 2010 Research Scholars Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Shamanic Healing and Spiritual Awakening, is happy to announce her “Spring Rejuvenation ... and body, these individual customized retreats offer the winter-weary soul an excellent opportunity ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has ... a company involved in the underground testing of nuclear weapons. Years later, when her ... Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by ...
(Date:2/27/2017)... ... 27, 2017 , ... Orange County dentist, Dr. A. Rassouli, comments ... occurs when the bacteria in plaque infect the gums and other tissues supporting the ... root planing or SRP, and can include surgical therapies if the condition has led ...
(Date:2/27/2017)... ... , ... Miro is the ultimate smart media center that offers a fascinating ... shows and much more apps for user exploration. Its innovative acoustic design with premium ... x 720 provides crisp images with remarkable clarity and color. The WiFi connection enables ...
(Date:2/27/2017)... Houston, TX (PRWEB) , ... February 27, 2017 ... ... the 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential ... Volterra Energy LLC in March 2014. The company had 800 customers and 2,250 ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Hemophilia market? What are the unit prices and ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
Breaking Medicine Technology: